)
Visual
test
Ensysce Biosciences
Ensysce Biosciences (ENSC) investor relations material
Ensysce Biosciences AGM 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2025 summary7 Jan, 2026
Opening remarks and agenda
The meeting was called to order virtually, with all board members introduced and the agenda outlined, including voting on five key proposals.
The virtual format was continued to ensure safety and accessibility for all stockholders.
Stockholders were informed about voting procedures and the opportunity to submit questions electronically.
Board and executive committee updates
Board composition was reviewed, with specific committee roles highlighted for each director.
Andrew Benton was acknowledged for his service as he is not standing for reelection.
Shareholder proposals
Proposal 1: Approval for full issuance of shares and exercise of warrants to comply with NASDAQ rules.
Proposal 2: Amendment to increase shares under the 2021 Omnibus Incentive Plan from 121,457 to 721,457.
Proposal 3: Election of William Chang and Lee Rauch as Class I Directors until 2028.
Proposal 4: Ratification of Baker Tilly US, LLP as independent auditor for 2025.
Proposal 5: Adjournment proposal, only to be considered if needed.
PF614 NDA submission target for early 2026
PF614-MPAR FDA labeling discussion outcome
Rationale for 2021 Omnibus Plan share increase
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Ensysce Biosciences
- Next-gen opioid therapies with anti-abuse and overdose protection advance toward market launch.ENSC
Investor Presentation7 Jan 2026 - Key votes on stock issuance, incentive plan, directors, and auditor set for January 7, 2026.ENSCProxy Filing16 Dec 2025
- Registers 4.6M shares for warrant/preferred conversion; faces liquidity and dilution risks.ENSCRegistration Filing16 Dec 2025
- Registering 29.5M shares underlying new warrants amid going concern and Nasdaq compliance risks.ENSCRegistration Filing16 Dec 2025
- High financial risk, dilution, and Nasdaq delisting concerns dominate this warrant-driven offering.ENSCRegistration Filing16 Dec 2025
- Registering 1.3M shares from warrants, with urgent capital needs and delisting risk.ENSCRegistration Filing16 Dec 2025
- Registering 980,000 shares for resale amid financial risk and no new capital raised.ENSCRegistration Filing16 Dec 2025
- Shareholders to vote on stock issuance, incentive plan, director elections, and auditor ratification.ENSCProxy Filing2 Dec 2025
- Proxy seeks approval for share issuances, reverse split, director elections, and auditor ratification.ENSCProxy Filing2 Dec 2025
Next Ensysce Biosciences earnings date
Q4 202531 Mar, 2026
Ensysce Biosciences
Next Ensysce Biosciences earnings date
Q4 202531 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage